Aspirin

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Aspirin

What is Aspirin?

Aspirin, also known chemically as acetylsalicylic acid, belongs to a group of medications called salicylates. It is a derivative of salicylic acid, a compound found naturally in the bark of willow trees, which has been used for its therapeutic properties for centuries.

Classification and Mechanism

Aspirin is classified as a nonsteroidal anti-inflammatory drug (NSAID). It functions by inhibiting the activity of enzymes known as cyclooxygenases, specifically COX-1 and COX-2. These enzymes are responsible for the production of prostaglandins, which are lipid compounds that act as signaling molecules in the body. By reducing prostaglandin synthesis, aspirin affects several physiological processes:

  • Analgesic properties: It helps reduce the sensation of pain.
  • Antipyretic properties: It assists in lowering elevated body temperatures.
  • Anti-inflammatory properties: It helps decrease swelling and inflammation in tissues.

Additional Effects

Beyond its role as an NSAID, aspirin possesses antiplatelet properties. It irreversibly inhibits the action of certain enzymes within platelets, preventing them from sticking together to form clots. Because of this unique mechanism, it is frequently utilized for its effects on the cardiovascular system and blood circulation.

Aspirin is available in various forms, including immediate-release tablets, delayed-release (enteric-coated) tablets, and buffered formulations, each designed to influence how the medication is absorbed by the body.

What side effects are possible with Aspirin?

Possible Side Effects and Safety Information

The official safety profile for Aspirin (acetylsalicylic acid) is structured by regulatory bodies to communicate its primary risks, which center on gastrointestinal toxicity and bleeding events. Adverse reactions are classified by frequency and grouped according to the affected organ system, based on clinical data and post-marketing surveillance.


Official Adverse Reaction Classification

Adverse effects are categorized within official labeling as affecting several System-Organ Classes (SOCs), including Gastrointestinal Disorders, Blood and Lymphatic System Disorders, Nervous System Disorders, and Immune System Disorders.

Frequency Category Examples of Officially Documented Effects
Common Dyspepsia, heartburn, abdominal pain, and minor, occult blood loss.
Uncommon Ulceration of the stomach or duodenum, clinical hemorrhage (e.g., epistaxis), and hypersensitivity reactions (e.g., urticaria).
Rare Major gastrointestinal bleeding, perforation, and cerebral hemorrhage.

Serious Safety Considerations

The most clinically significant risks documented include major hemorrhage, such as severe gastrointestinal or intracranial bleeding. A rare but serious condition, Reye's syndrome, is explicitly linked in regulatory documents to the use of Aspirin in children and adolescents recovering from viral infections, such as influenza or chickenpox. Severe hypersensitivity reactions, including anaphylaxis and asthma attacks (especially in patients with pre-existing asthma or nasal polyps), are also noted as serious adverse events.

Population-Specific Notes

The risk of serious adverse reactions, particularly gastrointestinal bleeding, is officially documented as being higher in older adults. Furthermore, the medicine is contraindicated in patients with severe hepatic or renal impairment, reflecting formal safety restrictions based on organ function.

Overdose and Emergency Response

The official overdose profile for acetylsalicylic acid (Aspirin) is classified by the progression of symptoms and life-threatening physiological disturbances. Early overdose, known as salicylism, typically presents with documented manifestations such as tinnitus (ringing in the ears), nausea, vomiting, and hyperventilation (rapid or deep breathing). As toxicity progresses, severe outcomes may include central nervous system effects such as confusion, seizures, and coma, alongside critical organ and metabolic failure. Documented complications include severe metabolic acidosis, noncardiogenic pulmonary edema, and acute renal failure. Population-specific notes indicate chronic overdose is often more serious in the elderly.

For any suspected overdose, official guidance mandates that you immediately contact emergency services or a Poison Control Center. Immediate medical attention is required for severe signs like seizures, trouble breathing, or loss of consciousness. No specific antidote is known for salicylate poisoning. Management described in regulatory documents is symptomatic and supportive, focusing on reducing absorption with activated charcoal and enhancing elimination via urinary alkalinization using intravenous sodium bicarbonate. In severe cases, hemodialysis is indicated to remove the salicylate and correct profound acid-base imbalances. Monitoring of serial serum salicylate levels and acid-base status is a required procedural step in the clinical management of poisoning.

Therapeutic Uses of Aspirin

Quick Facts

  • Relieves: Minor aches and pain (e.g., headache, muscle aches)
  • Reduces: Temporary fever
  • Assists with: Reducing the risk of certain serious cardiovascular events, such as heart attack and stroke, in specific patient populations under medical guidance
  • Manages: Signs and symptoms of select rheumatologic conditions

Aspirin is an established over-the-counter medicine utilized for the temporary relief from pain associated with various common ailments, including colds, toothache, and menstrual cramps. It is also indicated for the temporary reduction of fever.

Under the direction of a healthcare professional, Aspirin is also employed to reduce the risk of secondary cardiovascular and cerebrovascular events, such as recurrent myocardial infarction (heart attack) and ischemic stroke, in patients who have experienced a previous event or have established cardiovascular disease. Furthermore, it may help manage the signs and symptoms of specific inflammatory conditions like rheumatoid arthritis and osteoarthritis.

For its use in preventing major adverse cardiovascular events, the decision to initiate daily low-dose aspirin for primary prevention in adults aged 40 to 59 years is an individual one, based on a discussion between the patient and their clinician to balance potential benefits and harms. The medication is also utilized in the management of certain rare conditions, such as Kawasaki disease, under specialist care.

Regulatory References

  1. US Preventive Services Task Force guidance

Eligibility and Restrictions for Use

The eligibility for using Aspirin (Acetylsalicylic Acid, ASA) is strictly defined by regulatory authorities, with use generally permitted for adults for labeled indications, including pain relief and cardiovascular prevention.

Populations Who Must Not Use Aspirin (Contraindicated)

Use is prohibited for patients with specific health conditions or in certain physiological states, as outlined in official labeling:

  • Known hypersensitivity to ASA, salicylates, or other NSAIDs.
  • Active peptic ulcer disease or severe bleeding/coagulation disorders.
  • Severe hepatic impairment (liver disease) or severe renal impairment (kidney disease).
  • Pregnant patients during the third trimester of pregnancy.
  • Children or teenagers with a concurrent viral illness (e.g., flu or chickenpox), due to the risk of Reye's syndrome.

Age- and Condition-Based Restrictions

Population/Condition Regulatory Status
Children under 16 Generally not recommended for routine pain/fever.
Older Adults (Geriatrics) Use with caution due to increased susceptibility to adverse effects.
Pre-Surgery Must be suspended prior to scheduled surgery.
Breastfeeding Not recommended for regular or high-dose use.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section outlines the officially documented interaction patterns for Aspirin (Acetylsalicylic acid, ASA) as described in government regulatory information, focusing on changes in risk, plasma levels, or drug efficacy.

Documented High-Risk and Pharmacodynamic Interactions

Classification Interacting Agents Official Interaction Statement
Contraindicated Methotrexate (at doses ge 15 mg/week), Oral Anticoagulants (with high-dose ASA) High risk of toxicity or haemorrhage, based on reduced clearance or enhanced anti-clotting effects.
Increased Bleeding Risk Other Antiplatelet agents, SSRIs/SNRIs, Heparin Additive antiplatelet effects intensify the risk of haemorrhage.
Increased GI Risk Other Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Alcohol Synergistic effects increase the probability of gastrointestinal adverse events.

Pharmacokinetic and Efficacy Interactions

Aspirin's interaction profile includes effects on drug disposition and clearance. It can increase the plasma concentration of free Valproate and Phenytoin due to displacement from plasma protein binding sites. Aspirin may also reduce the intended therapeutic effect of certain medications: it officially inactivates the uricosuric effect of Probenecid by inhibiting renal tubular secretion, and it may reduce the effectiveness of Diuretics.

Regulatory-Specified Constraints

Regulatory documentation mandates a separation interval for certain combinations. To preserve the antiplatelet function of low-dose Aspirin, Ibuprofen must be administered at least 2 hours after a dose of immediate-release Aspirin. Additionally, Geriatric patients are officially noted as a population having a higher risk of major gastrointestinal bleeding when combined with other interacting agents.

Mechanism of Action

How Aspirin Works

Aspirin (Acetylsalicylic Acid) produces changes in physiological processes through the irreversible inhibition and acetylation of the Cyclooxygenase (COX) enzymes, specifically COX-1 and COX-2. This unique chemical modification permanently blocks the active site of the enzymes, preventing them from synthesizing crucial lipid mediators called eicosanoids.


Permanent Suppression of Platelet Aggregation

This mechanism targets COX-1 within platelets. Because platelets are anucleate (lacking a nucleus), the permanent inactivation of their COX-1 enzyme halts the synthesis of Thromboxane mathbfAmathbf2 (mathbfTXAmathbf2) for the cell's entire lifespan. This cascade results in a sustained reduction in mathbfTXAmathbf2-dependent platelet aggregation, affecting the body's hemostatic dynamics.


Dual Modulation of Inflammation and Nociception

This domain addresses the drug's action on mathbfCOX-2 in nucleated cells, including the central nervous system (CNS). Inhibiting COX-2 significantly reduces the synthesis of Prostaglandins, such as mathbfPGEmathbf2, which modifies the body’s thermoregulatory set point and reduces the sensitization of peripheral nociceptors. Furthermore, the acetylation of COX-2 reprograms its function to generate anti-inflammatory Aspirin-Triggered Lipoxins (ATLs), actively supports the resolution phase of the inflammatory response.

Dosage and Administration Information

How to Use Aspirin — Official Administration Guidelines

The administration of Aspirin (Acetylsalicylic Acid, ASA) is strictly governed by instructions that define its use based on the treatment pattern. The primary route is Oral (tablet, capsule), with Rectal (suppository) administration used when the oral route is not feasible.


Official Dosing and Frequency

Dosing regimens are distinct between acute and long-term scenarios. For acute, short-term use in adults (e.g., managing pain or fever), the standard dose is 325 mg to 650 mg per administration, taken every four to six hours as needed, and must not exceed 4,000 mg in 24 hours. For long-term prophylactic use, the regimen is a low dose, typically 75 mg to 150 mg, administered once daily.


Administration Requirements

Procedural Instruction Requirement Basis
Fluid Intake Take all oral doses with a full glass of water.
Food Intake May be taken with or after meals to minimize potential gastrointestinal intolerance.
Form Integrity Delayed-release or enteric-coated forms must be swallowed whole; they should not be cut, crushed, or chewed.

Usage Constraints

Aspirin is generally not indicated for routine administration in children and young people under 16 years of age. Its use in the pediatric population is limited to specific conditions and requires specialized, weight-based dosing and professional guidance. The official administration protocol mandates adherence to form-specific intake rules and clear separation of dosing schedules to maintain the drug’s intended therapeutic profile.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Aspirin


Evidence for Preventing First Heart Attack and Stroke

Research has extensively explored Aspirin's association with a first heart attack or stroke in individuals without a prior history of these events. This concept, often called preventing a first event, was studied for many years through large, randomized trials. Studies were conducted to see if patterns related to fewer serious events were observed in some groups, but these observations were studied alongside patterns related to serious internal bleeding.

Because of these mixed results, which require careful consideration of the findings observed, the overall evidence contributes to the broader evidence landscape but does not provide clear, consistent answers for all individuals. For many healthy individuals, data are still emerging regarding whether the observed patterns related to serious events outweigh the possible risks. Evidence is limited for long-term outcomes, and the results apply only to the populations studied.


Evidence for Preventing a Second Heart Attack or Stroke (Secondary Prevention)

Aspirin was evaluated in numerous clinical trials involving individuals who had already experienced a heart attack, stroke, or unstable angina. This research scenario explores the study of recurrence, often called preventing a second event. The studies focused on monitoring specific health outcomes following a first event.

Research examined how outcomes evolved in the observed populations when Aspirin was studied for this use alongside other standard care. Findings describe patterns observed in the studies that research examined for their possible association with the recurrence of these serious cardiovascular episodes.


Long-term Studies and Follow-up

Aspirin was studied for extended periods to understand patterns observed beyond the short term. While Aspirin was observed in trials with lengthy follow-up periods, research findings related to extended use are not fully established, particularly concerning patterns observed in studies that may change over time. Follow-up durations were limited in many studies, meaning that data for outcomes spanning decades are still insufficient.


Evidence in Special Populations

Research has explored how Aspirin was evaluated in various groups, including older adults or individuals with conditions marked by functional limitations. Sample sizes were modest in many of these specialized studies. Findings were mixed when trying to apply results from the main population studies to these special populations, and often the observed patterns appear to differ due to underlying health factors.


What is Still Uncertain about Aspirin

A significant amount of research is ongoing regarding Aspirin, but several key areas remain uncertain. The evidence highlights what is known—and what is still uncertain—regarding the optimal individual profile. Key evidence gaps include understanding how patterns related to bleeding precisely balance patterns related to cardiovascular events. The full extent of patterns observed in studies related to chronic conditions and patient-reported experience is still being explored.

Key Studies & References Recommendation: Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication (2022 USPSTF)

Frequently Asked Questions (FAQ)

Common questions about Aspirin (FAQ)

Q: What is the actual difference between Aspirin and Ibuprofen?

Official information describes Aspirin as both a Nonsteroidal Anti-inflammatory Drug (NSAID) and an antiplatelet agent. Ibuprofen is generally classified only as an NSAID. Aspirin is unique because it permanently modifies the activity of the COX enzyme, which is a key part of its antiplatelet function.

Q: Are there any common foods or drinks that interact with Aspirin?

Regulatory warnings specifically note that the concurrent consumption of alcohol increases the risk of stomach bleeding when taking Aspirin. Beyond general administration recommendations (such as taking with food), no common non-alcoholic foods or drinks are officially listed as a contraindication.

Q: What is the difference between Aspirin tablets and chewable Aspirin?

The key distinction is in the required administration procedure. According to official labeling, chewable tablets are typically intended to be thoroughly chewed before swallowing. Conversely, forms with a protective layer, such as delayed-release or enteric-coated tablets, are to be swallowed whole and should not be crushed, broken, or chewed.

Q: How long does the pain-relieving effect of Aspirin usually last?

For managing general pain or fever, official administration guidelines cite a dosing interval of every four to six hours as needed. This interval reflects the typical duration of the drug’s intended short-term therapeutic effect.

Q: Does taking Aspirin thin your blood permanently?

Aspirin permanently inhibits the action of a key enzyme, which modifies the clotting ability of individual platelets in the blood. However, platelets have a limited lifespan of about 8 to 9 days. As the body continuously replaces old platelets with new ones, the overall antiplatelet effect gradually fades as the affected cells are cleared.

Q: Is it okay to take Aspirin if I have asthma?

Official labeling notes that individuals with pre-existing asthma, particularly those with nasal polyps, are at a higher risk of severe hypersensitivity reactions, which can include asthma attacks. Official information indicates that professional guidance is necessary to assess the risks before use in this population.

Q: Is a person allowed to take Aspirin if they have a history of ulcers?

Active peptic ulcer disease is listed as an official contraindication, meaning the drug should not be used. However, those with a history of gastrointestinal disease or ulcers are noted to have an increased susceptibility to GI toxicity, so official safety information highlights that caution is necessary and a health professional must assess the risks before use.

Q: Why is Aspirin sometimes included in cold and flu remedies?

Aspirin is often combined with other ingredients in cold and flu remedies because it helps address common symptoms like pain and fever. Regulatory warnings, however, strictly reinforce the specific prohibition of its use in children and teenagers recovering from viral illnesses due to the documented risk of Reye's syndrome.

Q: What are the typical indications listed for high-dose Aspirin?

Higher-dose preparations are generally indicated for the short-term relief of mild to moderate pain and discomfort. This includes conditions such as headache, general aches, period pain, and for reducing fever and inflammation.

Q: How quickly does Aspirin start to work for general pain?

Official product information suggests that for general pain and fever relief, the therapeutic effects of the immediate-release form typically begin within 30 minutes of administration.

Q: What happens if I forget to take Aspirin one day?

Official instructions for a missed dose generally state that the dose is taken as soon as it is remembered, unless the time for the next scheduled dose is near. These rules emphasize that a double dose is not permitted to make up for a previously missed one.

Q: Are generic versions of Aspirin different from the brand name?

According to the Food and Drug Administration (FDA) standards for generic drugs, generic versions of Aspirin must contain the same active ingredient, strength, and work in the same way as the brand-name product. This consistency indicates they are expected to have the same risks and benefits.

Q: Does Aspirin cause drowsiness or make you tired?

Post-marketing surveillance has reported unusual drowsiness, dullness, or tiredness as possible side effects, though they are generally considered uncommon. This is noted in official adverse reactions sections.

Q: Is Aspirin still commonly used for treating arthritis?

Yes, high-dose Aspirin is indicated for the treatment of pain, inflammation, and rheumatic conditions. This includes indications for conditions such as rheumatoid arthritis and osteoarthritis.

Q: Are there any known interactions between Aspirin and common vitamins or supplements?

Regulatory documents mention that Aspirin may interfere with the function of Vitamin K, and official warnings highlight that caution is necessary in patients known to have a Vitamin K deficiency. No direct interactions with common daily vitamin supplements are generally reported.

Q: Can Aspirin affect blood sugar levels?

Official labeling notes that Aspirin can affect the body's blood sugar regulation. When taken with certain anti-diabetic medications, such as sulfonylureas, it may alter blood sugar levels and is described as increasing the risk of hypoglycemia.

Q: Can using Aspirin regularly cause ringing in the ears?

Ringing in the ears, medically known as tinnitus, or a loss of hearing are listed as documented side effects. Official product information indicates these are symptoms that warrant immediate discontinuation and seeking professional medical attention.

Q: Is there a maximum number of days or weeks that Aspirin should be taken for pain relief?

For self-treatment of pain or fever, official labeling states that the drug is generally constrained to a maximum of 10 days of use, unless otherwise guided by a health professional.

Q: Does research show Aspirin is effective for migraine pain?

Regulatory authorities indicate that Aspirin is specified for the treatment of acute migraine pain. It is often used in specialized products that combine it with other ingredients to enhance the intended effect.

How should Aspirin be stored and disposed of?

Official Aspirin Storage Requirements

Aspirin must be stored at controlled room temperature, typically 25 C (77 F), with permitted excursions up to 30 C (86 F). It is mandatory to protect the product from excess heat and moisture and to store it in its tightly closed, original container. Avoid storage in environments like bathrooms where heat and moisture are common.

Stability and Child Safety

To maintain stability, discard any tablets that have developed a strong vinegar smell, as this indicates product breakdown due to moisture. Aspirin must always be stored out of the sight and reach of children.

Official Disposal Instructions

Unused or expired aspirin should be disposed of using an authorized drug take-back program. If a take-back option is unavailable, the product must be mixed with an unappealing substance (like dirt or coffee grounds) and placed in a sealed container before throwing it into the household trash. The medicine must not be flushed down the toilet or sink.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Aspirin found in:

A-Z Index: